BioWorld - Tuesday, March 31, 2026

BioWorld Science

Sep. 10, 2021

View Archived Issues

AFYX Therapeutics presents preclinical data on anti-TNF antibody delivery through adhesive patch

Read More

Small-molecule OXS-7417 shows in vivo AML antitumoral effects

Read More

StemSynergy Therapeutics patents N-myc proto-oncogene protein inhibitors

Read More

Salk Institute, Sanford Burnham Prebys describe new ULK1 inhibitors

Read More

New PIKfyve inhibitors identified at AcuraStem

Read More

Discovery of novel antibiotic class of tethered macrocyclic peptides

Read More

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

Read More

HA-344 shows promise for treating cutaneous metastatic melanoma

Read More

PearlRiverBio patents mutant EGFR/HER2 inhibitors

Read More

STM-2457: a first-in-class METTL3 inhibitor with preclinical proof of concept in AML models

Read More

Flamingo and Ionis expand alliance to develop RNA-targeted therapies for oncology

Read More

GRC-39815 shows efficacy in models of smoke-induced COPD

Read More

Vitalgenics reports preclinical findings with excindogen in PDAC

Read More

Twist collaborates with Boehringer Ingelheim on antibody research programs

Read More

KG207-M, a novel bifunctional fusion protein as disease-modifying therapy for AD

Read More

Platinum(II)-NHC complex targeting vimentin inhibits tumor metastasis

Read More

fMLP receptor promotes inflammatory brain injury

Read More

At WCLC, early steps towards success against SCLC

Read More